An Australian company by the name of Imugene has recently developed a new virus that has been found to kill every type of cancer.

Researchers working for the biotechnology and immunotherapy corporation have reportedly come up with a new bioengineered virus, modified from smallpox, called CF33. CF33 has been shown to reduce cancer cells in laboratory mice.

Now, Imugene is looking at doing trials with humans to see if the virus is equally-effective at treating triple-negative breast cancer, melanoma, lung cancer, bladder, gastric, and bowel cancer.

Commenting on the possible breakthrough in an interview with British newspaper The Daily Telegraph, cancer expert Dr. Professor Yuman Fon stated:

"There was evidence that viruses could kill cancer from the early 1900s when people vaccinated against rabies had their cancer disappear, they went into remission. The problem was if you made the virus toxic enough to kill cancer you were worried it would also kill man."

The hope is that the virus can be 'programmed' biochemically to only attack malignant cancer cells in the body, ignoring non-cancerous ones. CF33 will be injected directly into the tumorous growths of patients, where they can multiply until they burst out of the tumor and kill it.

However, it should be noted that CF33 is still in the early stages of development, and we will need to wait for the concoction to be rigorously tested before it can be used to potentially save lives. Speaking to The Telegraph, Cancer Council chief Professor Sanchia Aranda stated: "When it is tested in a human we will see whether the immune system mounts a defense against the virus and knocks it off."

She added: "Cancer cells are very clever, they are true Darwinians that mutate to survive and there is a likelihood they will evolve to become resistant to the virus as they do now to become resistant to chemotherapy and immunotherapy."

An Australian company by the name of Imugene has recently developed a new virus that has been found to kill every type of cancer.

Researchers working for the biotechnology and immunotherapy corporation have reportedly come up with a new bioengineered virus, modified from smallpox, called CF33. CF33 has been shown to reduce cancer cells in laboratory mice.

Now, Imugene is looking at doing trials with humans to see if the virus is equally-effective at treating triple-negative breast cancer, melanoma, lung cancer, bladder, gastric, and bowel cancer.

Commenting on the possible breakthrough in an interview with British newspaper The Daily Telegraph, cancer expert Dr. Professor Yuman Fon stated:

"There was evidence that viruses could kill cancer from the early 1900s when people vaccinated against rabies had their cancer disappear, they went into remission. The problem was if you made the virus toxic enough to kill cancer you were worried it would also kill man."

The hope is that the virus can be 'programmed' biochemically to only attack malignant cancer cells in the body, ignoring non-cancerous ones. CF33 will be injected directly into the tumorous growths of patients, where they can multiply until they burst out of the tumor and kill it.

However, it should be noted that CF33 is still in the early stages of development, and we will need to wait for the concoction to be rigorously tested before it can be used to potentially save lives. Speaking to The Telegraph, Cancer Council chief Professor Sanchia Aranda stated: "When it is tested in a human we will see whether the immune system mounts a defense against the virus and knocks it off."

She added: "Cancer cells are very clever, they are true Darwinians that mutate to survive and there is a likelihood they will evolve to become resistant to the virus as they do now to become resistant to chemotherapy and immunotherapy."